Patient and physician preferences for atopic dermatitis injection treatments in Japan.

Recently, biologic agents administered as a subcutaneous injection have been introduced as treatment options for atopic dermatitis (AD). Biologic treatments differ considerably from traditional topical and systemic anti-inflammatory treatments, and it is unclear how this may impact patient and physician preferences for treatments. To examine the treatment preferences for new injection treatments of patients and physicians.